A GLP-1 program advertised from $139 a month sounds like a budget figure. At New Wave Health, it is better understood as the beginning of a pricing conversation. The homepage makes that amount subject to provider review without identifying the medication, formulation, supply quantity or program it purchases. The more consequential financial details appear elsewhere: bundled charges, immediate recurring billing, a promise of no dose-change surcharges and two different cancellation deadlines.
New Wave Health markets semaglutide, tirzepatide and a GLP-1 Microdose program. Its terms identify New Wave Health LLC as the website operator and describe it as a technology platform connecting patients with independent clinicians and pharmacies—not the entity providing clinical care or dispensing medication. This documentary review examines the sources consulted October 19, 2026, with an emphasis on what a prospective patient can establish about payment, included services and the remaining questions before enrollment.
At a glance
- Advertised starting price
- Plans start at $139 per month, subject to provider review; the published minimum is not linked to a specific medicine or supply quantity.Sources: [8]
- Recurring billing
- The terms authorize an immediate charge and another every 30 days until cancellation, with an electronic notice five to seven days before a scheduled transaction.Sources: [3]
- Bundled payment
- For applicable subscriptions, the total includes pharmacy charges, medical-group services and platform access.Sources: [3]
- Cancellation discrepancy
- Treatment FAQs require 30 days’ notice, while the terms describe cancellation through auto-refill controls at least 48 hours before monthly processing.
- Provider role
- New Wave Health LLC says it does not practice medicine, provide clinical care, prepare medications or dispense them; independent parties perform those functions.Sources: [3]
The starting price is not yet a treatment quote
The homepage’s “Plans from $139/mo” language is a starting-at offer, not a published price for every GLP-1 option. It also says pricing is confirmed after provider review. The supplied pages do not assign that minimum to semaglutide, tirzepatide or Microdose, nor do they specify the associated quantity. A reader therefore cannot use $139 to make a like-for-like comparison with a competing program that identifies its medication and supply.
There is useful pricing language beyond the headline. Treatment pages promise that pricing will be reviewed before anything is charged and that dose changes will not trigger surcharges. Tirzepatide is specifically presented as a flat-rate program. Those statements make the eventual written quote important: it should identify the program and product, what the charge covers and when it repeats. They do not independently establish a permanent price lock or a particular renewal price.
The consulted material does not document an introductory discount, a required prepaid package, a promotional code or a numerical price schedule for each treatment. It also does not establish that $139 is a first-month-only offer. The practical task is to obtain the actual offer rather than assume either a discount or a later increase. Our guide to understanding the first GLP-1 payment explains why the amount collected at enrollment deserves its own line in a budget.
| Item | Documented position | Question before payment |
|---|---|---|
| Starting price | From $139 per month after provider review | Which treatment and supply does my quote cover? |
| Dose changes | No dose-change surcharges advertised | Does that apply throughout my quoted program? |
| Included charges | Pharmacy, medical-group and platform charges bundled | Are labs or other services separate? |
| Billing interval | Immediate charge, then every 30 days | What is my exact next processing date? |
| Cancellation | 30-day and 48-hour rules both appear | Which written deadline applies to my enrollment? |
A bundled bill still needs an itemized explanation
New Wave Health’s terms describe a bundled payment when a subscription includes a consultation or prescription product. That total incorporates the pharmacy’s drug fee, the medical group’s professional-service fee and the platform’s own charge. The treatment pages add a service description: compounded medication, a dedicated provider, structured check-ins, direct messaging and discreet home delivery. This is more informative than a medication-only price, although it does not quantify every component.
The advertised whole-health plan considers nutrition, movement, sleep and stress. Patients are also told they can contact their provider through a secure portal between scheduled check-ins. However, the documents do not specify check-in frequency, clinical-message response times or the extent of individualized nutrition support. Those details affect the value of the bundle: access to messaging is not the same thing as a documented schedule of clinician contact.
Laboratory requirements and their costs are not established in the supplied material. The homepage says insurance is not required, but that does not answer whether New Wave Health accepts insurance, helps with reimbursement or supports HSA/FSA payment. These are separate budget questions, not reasons to presume coverage or exclusion. A useful comparison follows the approach in what a GLP-1 program price includes: match the promised services first, then compare the amounts.
The renewal clock runs every 30 days
The contractual billing language is more precise than the homepage’s monthly shorthand. By placing a recurring monthly order, a customer authorizes a charge immediately and every 30 days afterward until cancellation. The amount is the one listed for the applicable product on its purchase page. That makes the checkout record essential: the starting-price advertisement is not a substitute for the specific amount the customer authorizes.
A 30-day interval is not a calendar-month billing rule, and it is not a four-week cycle. New Wave Health says it sends electronic notice five to seven days before a scheduled transaction and a receipt after a successful charge. These notices can help track spending, but they should not be mistaken for the full cancellation window: one published cancellation rule requires substantially more advance notice than that reminder provides.
The documentation does not establish a minimum commitment or a particular supply quantity merely by describing recurring payments. Nor does it fully explain how the promise to review pricing before charging fits operationally with authorization for an immediate recurring-order charge. Before submitting payment, obtain the approved quote, first charge date and next processing date together. Our explanation of monthly and 30-day billing cycles provides a framework for recording those dates without treating them as interchangeable.
Resolve the cancellation conflict before enrolling
The largest documented financial ambiguity concerns stopping renewals. Treatment FAQs say memberships may be canceled with 30 days’ notice before the next billing cycle. The terms instead say a subscription can be canceled up to 48 hours before the monthly processing date by switching off auto-refill in the user portal. The supplied evidence does not explain whether these rules govern different arrangements or which would apply to a particular enrollment.
That difference matters because a customer following the shorter deadline could believe a renewal has been stopped while the other published wording suggests otherwise. The useful preparation is a written answer identifying the applicable notice period, cancellation method and final charge date. Save that answer along with the checkout terms and any portal confirmation. This is not a conclusion about which provision legally controls; the available contractual text also has an omitted intermediate section.
Refunds are a separate issue. The treatment FAQs state that consultations, medical visits and fulfilled prescriptions are nonrefundable once services begin or medication is processed. Canceling future billing therefore does not establish entitlement to money already paid. The documents do not fully explain the outcome when a prescription is declined or a charge precedes an unresolved fulfillment issue. The distinction between stopping a renewal and recovering a payment is explored in cancellation and refunds.
What the treatment menu actually documents
New Wave Health describes its semaglutide offering as a weekly injection, and its program includes compounded medication. Tirzepatide is marketed as a provider-directed dual GLP-1/GIP program with flat-rate pricing. The supplied tirzepatide text does not establish its administration route. The Microdose page describes a lower-dose GLP-1 protocol promoted for metabolic health, body composition and appetite rather than aggressive weight loss, but does not unequivocally identify its active ingredient or route.
Those distinctions prevent a meaningful medication comparison based on price alone. The company attributes preparation of its protocols to partner compounding pharmacies in the United States and acknowledges that compounded drugs are not FDA approved. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not prove clinical inequivalence, but neither provider marketing nor a low price establishes equivalence.
The homepage also promotes clinician-reviewed peptide therapies, expanding the business beyond its GLP-1 offerings. Within the GLP-1 menu, Microdose is marketed partly toward people near their goal weight or those who poorly tolerated standard programs; its page excludes people it considers better served by a standard protocol because they have significant weight to lose. These are provider descriptions, not demonstrated benefits. The supplied evidence does not establish the clinical effectiveness of New Wave Health’s specific compounded preparations or Microdose protocol.
Enrollment buys access to review, not a guaranteed prescription
The advertised entry point is an online assessment covering health history, weight goals and baseline measurements, estimated to take five to ten minutes. An account with a username and password is required to access the service. The terms then make prescription access conditional on a consultation, a provider’s determination that the product is appropriate and issuance of a prescription. Completing an intake or agreeing to payment does not itself establish approval.
The general terms restrict access to people at least 18, or the local age of majority if higher. The semaglutide page describes candidates as adults with BMI of at least 27, or at least 25 with weight-related conditions. Its standard-program exclusions include personal or family history of medullary thyroid carcinoma or MEN 2; pregnancy, breastfeeding or planned pregnancy; and active pancreatitis or untreated severe gastrointestinal disease. These are the provider’s stated screening criteria, not individualized eligibility advice.
The platform says independent providers exercise their own professional judgment, and it advertises access to U.S. board-certified clinical providers and state-licensed compounding pharmacies. The supplied sources do not name the clinicians, medical groups or dispensing pharmacies or independently verify their credentials. For a buyer, this is a responsibility question as much as a medical one: establish who handles assessment, prescribing, follow-up and pharmacy problems before assuming a single bundled bill means one organization performs every service.
Delivery is included, but geography and pharmacy choice have limits
The homepage promotes nationwide delivery, while treatment pages describe telehealth care in Virginia and states where the providers are licensed. A complete state list is not supplied. The terms also require patients to be physically in the same state as their account’s shipping address when consulting a provider. Shipping reach therefore cannot be read as nationwide clinical availability, especially for someone traveling or seeking care from a different location.
Medication is sent directly by the relevant pharmacy, and the terms require acceptance of the platform’s pharmacy rather than filling the prescription at a pharmacy of the patient’s choice. The treatment page advertises temperature-controlled, unmarked packaging delivered to the home. It does not supply a carrier, preparation timeline, dispatch deadline or arrival estimate. Included delivery is a service feature, not a documented promise that medication will arrive by a particular day.
Two practical boundaries deserve attention before paying. First, the terms say prescription products will not be dispensed in child-resistant containers. Second, the available sources do not establish a replacement or refund policy for lost shipments or temperature problems. FDA explicitly advises not using an injectable GLP-1 drug that arrives warm or with insufficient refrigeration and contacting the provider or dispensing pharmacy. That guidance does not tell a customer who will bear any replacement cost.
Support and privacy are part of the purchase
New Wave Health publishes Dgraves@mynewwavehealth.com and +1 757-573-0882 for support, with clinical hours listed as Monday through Friday, 9 a.m. to 5 p.m. Its contact form advertises a response within 24 hours. That is an inquiry-response statement, not a documented deadline for clinical review, prescription approval or shipping. The company also lists a mailing address at 1832 Kempsville Road, Suite 112, Virginia Beach, VA 23464.
The intake is promoted as secure and HIPAA-compliant, but the terms say New Wave Health LLC is not itself a HIPAA covered entity and may act as a business associate of a pharmacy or medical group in some circumstances. These statements describe different roles and should be read together. A broad privacy assurance should not replace checking which entity receives medical information and which organization is responsible for the clinical record.
There are also differences in the data-sharing descriptions. Treatment FAQs describe sharing only with the provider and pharmacy, while the general policy permits service-provider access for payments, hosting, marketing, support and analytics as needed for their duties. The California notice says some advertising disclosures may qualify as a sale or sharing under that law, qualifying the broader no-sale statement. The supplied documents do not resolve those differences; prospective patients should read the fuller policy before submitting sensitive intake information.
Questions & answers
Can I enroll in New Wave Health semaglutide for $139?
The supplied pages do not establish that. They advertise plans from $139 per month, confirmed after provider review, without connecting that minimum to semaglutide or a particular supply. Ask for the medication, formulation, quantity, included services and recurring amount in one written quote. The treatment pages promise pricing review before charging and no dose-change surcharges, but that is not a published semaglutide price schedule.
Does New Wave Health charge on the same date every month?
Its terms describe an immediate charge followed by charges every 30 days, not a fixed calendar date each month. They also promise electronic notice five to seven days before a scheduled transaction. Record the processing date shown for your own subscription rather than relying on the word “monthly.” The documents do not establish a separate medication supply quantity simply by specifying that billing interval.
How much notice does New Wave Health require to cancel?
The documents give conflicting answers. Treatment FAQs specify 30 days before the next billing cycle; the terms describe turning off auto-refill in the portal at least 48 hours before monthly processing. The supplied evidence does not resolve which applies to a particular purchase. Obtain written clarification before enrollment, including the final charge date. Cancellation also does not override the stated nonrefundability of services already begun or medication already processed.
Can I use my own pharmacy through this program?
The terms require patients purchasing a service that includes a prescription to accept the platform’s pharmacy channel rather than choose another pharmacy. They say the pharmacy sends medication directly to the patient. The supplied sources do not name the dispensing partners, so ask which pharmacy would fill your prescription and how to contact it. The bundled price should not be assumed transferable to a local or independently selected pharmacy.
Is New Wave Health available outside Virginia?
Treatment pages say it serves Virginia and states where its providers are licensed, but the consulted material does not provide a complete list. Nationwide delivery advertising does not confirm clinical availability in every state. The terms additionally require your physical location during consultation to match the state of your shipping address. Confirm both your state’s eligibility and your location at consultation before assuming the program can serve you.
Who should I contact about a charge or delayed response?
The published support routes are Dgraves@mynewwavehealth.com and +1 757-573-0882, alongside a contact form advertising a response within 24 hours. Clinical hours are listed as weekdays from 9 a.m. to 5 p.m. Keep billing questions distinct from clinical portal messages: the site advertises direct provider messaging but does not establish its response time. The contact-form promise should not be treated as a deadline for resolving a charge or approving treatment.
Our assessment
New Wave Health documents a potentially convenient bundled model: compounded medication, professional services, portal messaging, check-ins and home delivery, with advertised protection against dose-change surcharges. Its terms also explain the platform’s separate role and the components of the bundled charge. The weakness is not the absence of any price; it is that the $139 starting figure cannot be assigned to a defined treatment, while renewal and cancellation details require careful reconciliation. Before paying, obtain a treatment-specific quote, confirm the 30-day processing dates, resolve the 30-day-versus-48-hour cancellation conflict and identify the clinician and dispensing pharmacy. State availability, laboratory costs and shipment-problem responsibilities also remain material questions. The documented offer is worth evaluating on those written answers—not on the starting price alone.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- New Wave Health — treatments/tirzepatide ↗
- New Wave Health — terms ↗
- New Wave Health — privacy ↗
- New Wave Health — treatments/glp 1 microdose ↗
- New Wave Health — treatments/semaglutide ↗
- New Wave Health — contact ↗
- New Wave Health — official website ↗